Cargando…
Tofacitinib as a novel therapy in COVID-19 acute respiratory distress syndrome
Autores principales: | Panda, Rajesh, Singh, Pooja, Kodamanchili, Saiteja, Anand, Abhijeet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613470/ https://www.ncbi.nlm.nih.gov/pubmed/34908570 http://dx.doi.org/10.4103/ija.ija_817_21 |
Ejemplares similares
-
Heparin-induced hyponatremia in COVID-19: A latent culprit!
por: Panda, Rajesh, et al.
Publicado: (2021) -
Trendelenburg Ventilation in Patients of Acute Respiratory Distress Syndrome with Poor Lung Compliance and Diaphragmatic Dysfunction
por: Kodamanchili, Saiteja, et al.
Publicado: (2022) -
Author's Response to Trendelenburg Ventilation in Acute Respiratory Distress Syndrome: Should We Do More than Proning?
por: Kodamanchili, Saiteja
Publicado: (2022) -
Novel Use of Catheter Mount as an Alternative to T-piece
por: Anand, Abhijeet, et al.
Publicado: (2022) -
Effect of Remdesivir Administration on Occurrence of Major Adverse Cardiac Events in Critically Ill COVID-19 Pneumonia: A Retrospective Observational Study
por: Panda, Rajesh, et al.
Publicado: (2022)